Epidermal growth factor receptor 2 (HER2) is a biomarker for early cancer diagnosis once it is known to be overexpressed in many types of cancer such as breast, lung, gastric, ovarian, and oral cancer. The gene discussed is ERBB2; the disease is cancer.